文献速递细菌感染、耐药与抗菌药物艾滋病与性传播感染

美国临床研究队列中女性泌尿生殖道标本内大环内酯耐药生殖支原体的分布

Distribution of Macrolide Resistant Mycoplasma genitalium in Urogenital Tract Specimens From Women Enrolled in a US Clinical Study Cohort.
PubMed 文献 · Clin Infect Dis · 2023-01-01

本研究在美国多中心前瞻性临床研究入组女性中,采集阴道拭子、尿液、宫颈管拭子及宫颈外口刷/刮板四种标本,用TMA检测生殖支原体,阳性标本行23S rRNA测序识别大环内酯耐药突变。140例至少一份标本TMA阳性的女性中128例获得序列,阴道标本耐药突变占52%,阴道拭子对识别大环内酯耐药感染的敏感性最高(96.3%)。

要点

  • 140例至少一份TMA阳性女性中128例(91.4%)获得生殖支原体23S rRNA序列。
  • 大环内酯耐药突变在阴道标本占52%、尿液占46.3%、宫颈管标本占37.8%、宫颈外口标本占46%。
  • 阴道拭子检测泌尿生殖道大环内酯耐药生殖支原体感染的敏感性为96.3%。

核心结论

  • 女性泌尿生殖道生殖支原体感染分布高度复杂,相当比例女性在不同解剖部位采集标本中存在多种表型组合。
  • 阴道拭子采样对识别女性泌尿生殖道大环内酯耐药生殖支原体感染的敏感性最高。

研究设计与样本

  • 美国多中心前瞻性临床研究,每名受试者采集阴道拭子、尿液、宫颈管拭子、宫颈外口刷/刮板四种女性泌尿生殖道标本。
  • 标本用转录介导扩增(TMA)检测生殖支原体,阳性标本行逆转录聚合酶链反应及23S rRNA双向Sanger测序识别2058/2059位大环内酯耐药突变。
  • 共140例至少一份标本TMA阳性的女性纳入分析。

主要发现

  • 140例至少一份TMA阳性女性中128例(91.4%)获得生殖支原体23S rRNA序列。
  • 大环内酯耐药突变在阴道标本占52%、尿液标本占46.3%、宫颈管标本占37.8%、宫颈外口标本占46%。
  • 生殖支原体感染的标本类型/序列表型组合共有44种。
  • 81例(63.3%)女性为单一标本-序列表型感染,24例(18.8%)为多种标本-序列表型一致感染,23例(17.9%)为多种标本-序列表型不一致感染。
  • 任一单种标本检测整体泌尿生殖道大环内酯耐药生殖支原体感染状态的敏感性:阴道拭子96.3%、尿液82.6%、宫颈管拭子70.8%、宫颈外口刷/刮板液基巴氏标本82.1%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study evaluated the distribution of macrolide-resistant Mycoplasma genitalium in multiple urogenital specimens collected from women enrolled in a prospective multicenter US clinical study. METHODS: Four female urogenital specimens (vaginal swab, urine, endocervical swab, ectocervical brush/spatula) collected from each subject were tested using a transcription-mediated amplification (TMA) assay for M. genitalium. TMA-positive specimens were evaluated by reverse transcription-polymerase chain reaction and bidirectional Sanger sequencing of M. genitalium 23S rRNA to identify the presence of macrolide-resistance-mediating mutations (MRMs) at base positions 2058/2059. RESULTS: Of 140 women with ≥1 TMA-positive specimens, 128 (91.4%) yielded M. genitalium 23S rRNA sequence. MRMs were found in 52% of vaginal specimens, 46.3% of urine specimens, 37.8% of endocervical specimens, and 46% of ectocervical specimens. There were 44 unique specimen type/sequence phenotype combinations of M. genitalium infection. Most (81; 63.3%) women had single specimen-sequence phenotype (macrolide-susceptible, MRM, or both) infections, while 24 (18.8%) women had multiple specimen-sequence phenotype concordant infections, and 23 (17.9%) women had multiple specimen-sequence phenotype discordant infections. The sensitivity for any single specimen type to detect overall urogenital tract macrolide-resistant M. genitalium infection status was 96.3% for vaginal swab samples, 82.6% for urine samples, 70.8% for endocervical swab samples, and 82.1% for ectocervical brush/spatula liquid Pap samples. CONCLUSIONS: The distribution of M. genitalium infections in female urogenital tract specimens is highly complex, with multiple phenotypic combinations of the organism infecting a significant proportion of women at different anatomic specimen collection sites. Vaginal swab sampling yielded the highest sensitivity for identifying women with macrolide-resistant M. genitalium urogenital tract infections.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Getman D, Cohen S, Jiang A, et al. Distribution of Macrolide Resistant Mycoplasma genitalium in Urogenital Tract Specimens From Women Enrolled in a US Clinical Study Cohort. Clin Infect Dis. 2023. PMID: 35870121. doi:10.1093/cid/ciac602

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。